TNF and stroke disorder: Although none of the various aspects of the study are particularly novel (naloxone effects on stroke have been reported, intranasal naloxone administration has been used in both humans and rodents, and naloxone has been shown to suppress microglial activation and TNF in other inflammatory contexts), the use of intranasal naloxone to suppress stroke-induced microglial activation, which presumably then improves stroke outcome, is innovative.